Memphis Pharmaceutical & Chemical Industries (MPCI) Financials
Annual financial statement highlights for Memphis Pharmaceutical & Chemical Industries covering fiscal years 2005–2025. Figures are updated weekly.
| Fiscal year | Revenue | Net income | EPS | Free cash flow | Total assets | Total debt | Dividend per share |
|---|---|---|---|---|---|---|---|
| 2025ended Jun 2025 | 1.51B | 505.28M | 22.21 | 197.98M | 1.49B | 101.6M | 13.19 |
| 2024ended Jun 2024 | 871.91M | 191.46M | 11.33 | 213.8M | 1.22B | 177.04M | 4.00 |
| 2023ended Jun 2023 | 663.83M | 90.44M | 5.35 | 57.36M | 785.66M | 13.32M | 0.67 |
| 2022ended Jun 2022 | 551.26M | 74.09M | 4.38 | 31.23M | 560.29M | 4.73M | 0.00 |
| 2021ended Jun 2021 | 518.11M | 41.81M | 2.47 | 6.09M | 431.58M | 5.36M | 0.00 |
| 2020ended Jun 2020 | 490.1M | 17.41M | 1.03 | -1.45M | 377.41M | 0 | 0.00 |
| 2019ended Jun 2019 | 366.84M | -25.38M | -1.50 | 270,000 | 342.75M | 1.61M | 0.00 |
| 2018ended Jun 2018 | 343.36M | -46.74M | -2.77 | 20.9M | 375.24M | 37.88M | 0.00 |
| 2017ended Jun 2017 | 250.21M | -34.22M | -2.03 | -6.02M | 330.65M | 10.06M | 0.00 |
| 2016ended Jun 2016 | 357.8M | 90,000 | 0.01 | 9.43M | 313.61M | 82M | 0.00 |
| 2015ended Jun 2015 | 396.15M | -10.28M | -0.61 | -5.03M | 286.69M | 85.27M | 0.00 |
| 2014ended Jun 2014 | 422.68M | 2.22M | 0.13 | -4.02M | 246.34M | 25.01M | 0.00 |
| 2013ended Jun 2013 | 398.22M | 4.62M | 0.27 | — | 230.01M | 0 | 0.08 |
| 2012ended Jun 2012 | 278.99M | 1.04M | 0.06 | 6.57M | 229.91M | 0 | 0.08 |
| 2011ended Jun 2011 · 24 months | 350.99M | 5.51M | 0.33 | 2.9M | 269.08M | 0 | 0.25 |
| 2009ended Jun 2009 · 36 months | 445.51M | 9.58M | 0.57 | 6.79M | 247.76M | 90,000 | 0.43 |
| 2006ended Jun 2006 | 174.11M | 26.05M | 1.54 | 21.32M | 224.43M | 1.79M | 0.44 |
| 2005ended Jun 2005 | 163.12M | 22.79M | 1.35 | 14.07M | 229.91M | 3.08M | 1.07 |
All figures in EGP, as reported in the company’s annual results; updated weekly.